Loading...
Loss of Pkd1 limits susceptibility to colitis and colorectal cancer
Nikonova, Anna S. Deneka, Alexander Y. Silva, Flaviane N. Pirestani, Shabnam Kiseleva, Anna A. Zhou, Yan Nicolas, Emmanuelle Flieder, Douglas B. Grivennikov, Sergei I.
Nikonova, Anna S.
Deneka, Alexander Y.
Silva, Flaviane N.
Pirestani, Shabnam
Kiseleva, Anna A.
Zhou, Yan
Nicolas, Emmanuelle
Flieder, Douglas B.
Grivennikov, Sergei I.
Citations
Altmetric:
Genre
Journal article
Date
2023-08-05
Advisor
Committee member
Department
Cancer and Cellular Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1038/s41389-023-00486-y
Abstract
Colorectal cancer (CRC) is one of the most common cancers, with an annual incidence of ~135,000 in the US, associated with ~50,000 deaths. Autosomal dominant polycystic kidney disease (ADPKD), associated with mutations disabling the PKD1 gene, affects as many as 1 in 1000. Intriguingly, some studies have suggested that individuals with germline mutations in PKD1 have reduced incidence of CRC, suggesting a genetic modifier function. Using mouse models, we here establish that loss of Pkd1 greatly reduces CRC incidence and tumor growth induced by loss of the tumor suppressor Apc. Growth of Pkd1−/−;Apc−/− organoids was reduced relative to Apc−/− organoids, indicating a cancer cell-intrinsic activity, even though Pkd1 loss enhanced activity of pro-oncogenic signaling pathways. Notably, Pkd1 loss increased colon barrier function, with Pkd1-deficient animals resistant to DSS-induced colitis, associated with upregulation of claudins that decrease permeability, and reduced T cell infiltration. Notably, Pkd1 loss caused greater sensitivity to activation of CFTR, a tumor suppressor in CRC, paralleling signaling relations in ADPKD. Overall, these data and other data suggest germline and somatic mutations in PKD1 may influence incidence, presentation, and treatment response in human CRC and other pathologies involving the colon.
Description
Citation
Nikonova AS, Deneka AY, Silva FN, Pirestani S, Tricarico R, Kiseleva AA, et al. Loss of Pkd1 limits susceptibility to colitis and colorectal cancer. Oncogenesis. 2023 Aug 5;12(40). doi:10.1038/s41389-023-00486-y.
Citation to related work
Springer Nature
Has part
Oncogenesis, Vol. 12
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu